{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:20:59Z","timestamp":1792102859420,"version":"4.4.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.heliyon.2024.e32602","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T20:34:49Z","timestamp":1718224489000},"page":"e32602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Research progress of nano delivery systems for intraocular pressure lowering drugs"],"prefix":"10.1016","volume":"10","author":[{"given":"Xiaoyu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3148-1703","authenticated-orcid":false,"given":"Xuanchu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e32602_bib1","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(23)01289-8","article-title":"Glaucoma: now and beyond","volume":"402","author":"Jayaram","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2024.e32602_bib2","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s40123-022-00557-0","article-title":"A narrative review of ocular surface disease related to anti-glaucomatous medications","volume":"11","author":"Zhou","year":"2022","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.heliyon.2024.e32602_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eyedrops: the good, the bad and the ugly","volume":"29","author":"Baudouin","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.heliyon.2024.e32602_bib4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jconrel.2023.08.041","article-title":"An insight on ophthalmic drug delivery systems: focus on polymeric biomaterials-based carriers","volume":"362","author":"Shafiq","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.heliyon.2024.e32602_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1548","article-title":"Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases","volume":"11","author":"Srinivasarao","year":"2019","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.heliyon.2024.e32602_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-60761-609-2_14","article-title":"Preparation and characterization of doxorubicin liposomes","volume":"624","author":"Niu","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.heliyon.2024.e32602_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/ICU.0000000000000933","article-title":"Advances in innovative delivery systems for antiglaucoma drugs","volume":"34","author":"Chen","year":"2023","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.heliyon.2024.e32602_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25163731","article-title":"Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology","volume":"25","author":"Zielinska","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e32602_bib9","article-title":"Breaking barriers in eye treatment: polymeric nano-based drug-delivery system for anterior segment diseases and glaucoma","volume":"15","author":"Wu","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/j.heliyon.2024.e32602_bib10","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1097\/IJG.0000000000000122","article-title":"Noninvasive ocular drug delivery: potential transcorneal and other alternative delivery routes for therapeutic molecules in glaucoma","volume":"23","author":"Foldvari","year":"2014","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.heliyon.2024.e32602_bib11","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/abca5f","article-title":"A wearable contact lens sensor for noninvasive in-situ monitoring of intraocular pressure","volume":"32","author":"Fan","year":"2021","journal-title":"Nanotechnology"},{"key":"10.1016\/j.heliyon.2024.e32602_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123161","article-title":"Morphologic design of nanogold carriers for a carbonic anhydrase inhibitor: effect on ocular retention and intraocular pressure","volume":"642","author":"Eissa","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.heliyon.2024.e32602_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202170034","article-title":"Lollipop-inspired multilayered drug delivery hydrogel for dual effective, long-term, and NIR-defined glaucoma treatment","volume":"21","author":"Wang","year":"2021","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.heliyon.2024.e32602_bib14","first-page":"29","article-title":"Clinical outcomes of amniotic membrane loaded with 5-FU PLGA nanoparticles in experimental trabeculectomy","volume":"8","author":"Hu","year":"2015","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.heliyon.2024.e32602_bib15","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.apsb.2020.03.002","article-title":"Inhibition of post-trabeculectomy fibrosis via topically instilled antisense oligonucleotide complexes co-loaded with fluorouracil","volume":"10","author":"Jiang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.heliyon.2024.e32602_bib16","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1039\/D1BM01614H","article-title":"A graphene-Ag based near-infrared defined accurate anti-scarring strategy for ocular glaucoma surgery","volume":"10","author":"Wang","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.heliyon.2024.e32602_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2023.100922","article-title":"A novel adjustable PHBV basement film for enhancing the efficacy of glaucoma surgery by inhibiting scar formation","volume":"24","author":"Zhou","year":"2024","journal-title":"Materials Today Bio"},{"key":"10.1016\/j.heliyon.2024.e32602_bib18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/BF02169795","article-title":"Comparison of different models for the testing of pilocarpine eyedrops using conventional eyedrops and a novel depot formulation (nanoparticles)","volume":"227","author":"Diepold","year":"1989","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.heliyon.2024.e32602_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1211\/jpp.58.2.0004","article-title":"Characterization of pilocarpine-loaded chitosan\/Carbopol nanoparticles","volume":"58","author":"Kao","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e32602_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1163\/156856207779116739","article-title":"Pilocarpine-loaded chitosan-PAA nanosuspension for ophthalmic delivery","volume":"18","author":"Lin","year":"2007","journal-title":"J Biomater Sci Polym"},{"key":"10.1016\/j.heliyon.2024.e32602_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1021\/acsomega.7b01421","article-title":"Validation of smart nanoparticles as controlled drug delivery systems: loading and pH-dependent release of pilocarpine","volume":"3","author":"Galbis","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.heliyon.2024.e32602_bib22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.actbio.2020.04.055","article-title":"Effects of shell thickness of hollow poly(lactic acid) nanoparticles on sustained drug delivery for pharmacological treatment of glaucoma","volume":"111","author":"Nguyen","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.heliyon.2024.e32602_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119961","article-title":"Dually functional hollow ceria nanoparticle platform for intraocular drug delivery: a push beyond the limits of static and dynamic ocular barriers toward glaucoma therapy","volume":"243","author":"Luo","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.heliyon.2024.e32602_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.138620","article-title":"Amination-mediated nano eye-drops with enhanced corneal permeability and effective burst release for acute glaucoma treatment","volume":"451","author":"Nguyen","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.heliyon.2024.e32602_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105553","article-title":"Topical ocular pharmacokinetics and bioavailability for a cocktail of atenolol, timolol and betaxolol in rabbits","volume":"155","author":"Fayyaz","year":"2020","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.heliyon.2024.e32602_bib26","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1080\/03639040701384942","article-title":"Chitosan nanoparticles for prolonged delivery of timolol maleate","volume":"33","author":"Agnihotri","year":"2007","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.heliyon.2024.e32602_bib27","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/02713680903017500","article-title":"Sustained release and permeation of timolol from surface-modified solid lipid nanoparticles through bioengineered human cornea","volume":"34","author":"Attama","year":"2009","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.heliyon.2024.e32602_bib28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jconrel.2012.10.010","article-title":"Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lenses","volume":"165","author":"Jung","year":"2013","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.heliyon.2024.e32602_bib29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/jop.2012.0114","article-title":"Extended release of timolol from nanoparticle-loaded fornix insert for glaucoma therapy","volume":"29","author":"Jung","year":"2013","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.heliyon.2024.e32602_bib30","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2012.10.015","article-title":"Development of O\/W nanoemulsions for ophthalmic administration of timolol","volume":"440","author":"Gallarate","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.heliyon.2024.e32602_bib31","first-page":"310","article-title":"Development of timolol maleate loaded chitosan nanoparticles for improved ocular delivery","volume":"5","author":"Saroha","year":"2017","journal-title":"Pharm. Nanotechnol."},{"key":"10.1016\/j.heliyon.2024.e32602_bib32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.actbio.2019.01.004","article-title":"Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: in vitro and in vivo evaluation","volume":"86","author":"Maulvi","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.heliyon.2024.e32602_bib33","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.exer.2017.10.002","article-title":"Co-instillation of nano-solid magnesium hydroxide enhances corneal permeability of dissolved timolol","volume":"165","author":"Nagai","year":"2017","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.heliyon.2024.e32602_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/vetsci8080168","article-title":"Magnesium hydroxide nanoparticles improve the ocular hypotensive effect of twice daily topical timolol maleate in healthy dogs","volume":"8","author":"Kita","year":"2021","journal-title":"Vet Sci"},{"key":"10.1016\/j.heliyon.2024.e32602_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111383","article-title":"Mucoadhesive and responsive nanogels as carriers for sustainable delivery of timolol for glaucoma therapy","volume":"118","author":"Cuggino","year":"2021","journal-title":"Mater. Sci. Eng., C"},{"key":"10.1016\/j.heliyon.2024.e32602_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/polym14030427","article-title":"The effect of polymers on drug release kinetics in nanoemulsion in situ gel formulation","volume":"14","author":"Vijaya Rani","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.heliyon.2024.e32602_bib37","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1021\/acs.molpharmaceut.1c00766","article-title":"In situ gelling electrospun ocular films sustain the intraocular pressure-lowering effect of timolol maleate: in vitro, ex vivo, and pharmacodynamic assessment","volume":"19","author":"Andreadis","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.heliyon.2024.e32602_bib38","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjo.86.4.418","article-title":"Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication","volume":"86","author":"Pisella","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.heliyon.2024.e32602_bib39","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/archopht.1995.01100120044006","article-title":"Effects of brimonidine on aqueous humor dynamics in human eyes","volume":"113","author":"Toris","year":"1995","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.heliyon.2024.e32602_bib40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10792-024-03095-9","article-title":"Axonal protection by combination of ripasudil and brimonidine with upregulation of p-AMPK in TNF-induced optic nerve degeneration","volume":"44","author":"Otsubo","year":"2024","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.heliyon.2024.e32602_bib41","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ajo.2010.09.026","article-title":"A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study","volume":"151","author":"Krupin","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.heliyon.2024.e32602_bib42","first-page":"CD006539","article-title":"Neuroprotection for treatment of glaucoma in adults","volume":"1","author":"Sena","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.heliyon.2024.e32602_bib43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/02652040309178075","article-title":"Brimonidine formulation in polyacrylic acid nanoparticles for ophthalmic delivery","volume":"20","author":"De","year":"2003","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.heliyon.2024.e32602_bib44","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2174\/156720110791561008","article-title":"Development and evaluation of novel polymeric nanoparticles of brimonidine tartrate","volume":"7","author":"Singh","year":"2010","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.heliyon.2024.e32602_bib45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/tvst.4.3.12","article-title":"Natural bioadhesive biodegradable nanoparticle-based topical ophthalmic formulations for management of glaucoma","volume":"4","author":"Ibrahim","year":"2015","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.heliyon.2024.e32602_bib46","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1007\/s11095-013-1109-1","article-title":"Novel topical ophthalmic formulations for management of glaucoma","volume":"30","author":"Ibrahim","year":"2013","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.heliyon.2024.e32602_bib47","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1208\/s12249-011-9643-9","article-title":"Nanovesicular formulation of brimonidine tartrate for the management of glaucoma: in vitro and in vivo evaluation","volume":"12","author":"Maiti","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.heliyon.2024.e32602_bib48","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4103\/0975-1483.71623","article-title":"Preparation and evaluation of nano-vesicles of brimonidine tartrate as an ocular drug delivery system","volume":"2","author":"Prabhu","year":"2010","journal-title":"J. Young Pharm."},{"key":"10.1016\/j.heliyon.2024.e32602_bib49","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1208\/s12249-011-9675-1","article-title":"Brimonidine tartrate-eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation","volume":"12","author":"Bhagav","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.heliyon.2024.e32602_bib50","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jconrel.2015.10.027","article-title":"Mucoadhesive microparticles with a nanostructured surface for enhanced bioavailability of glaucoma drug","volume":"220","author":"Park","year":"2015","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.heliyon.2024.e32602_bib51","doi-asserted-by":"crossref","first-page":"7990","DOI":"10.1021\/acsami.6b16509","article-title":"Sustained release of brimonidine from a new composite drug delivery system for treatment of glaucoma","volume":"9","author":"Sun","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.heliyon.2024.e32602_bib52","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1021\/acsbiomaterials.7b00319","article-title":"Fast dissolving dendrimer nanofiber mats as alternative to eye drops for more efficient antiglaucoma drug delivery","volume":"3","author":"Lancina","year":"2017","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.heliyon.2024.e32602_bib53","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1017\/S1431927619000448","article-title":"Effect of ultra-small chitosan nanoparticles doped with brimonidine on the ultra-structure of the trabecular meshwork of glaucoma patients","volume":"25","author":"Barwal","year":"2019","journal-title":"Microsc. Microanal."},{"key":"10.1016\/j.heliyon.2024.e32602_bib54","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/02652048.2018.1425753","article-title":"Nanostructured lipid carriers for intraocular brimonidine localisation: development, in-vitro and in-vivo evaluation","volume":"35","author":"El-Salamouni","year":"2018","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.heliyon.2024.e32602_bib55","doi-asserted-by":"crossref","first-page":"9445","DOI":"10.1021\/acsami.0c18626","article-title":"Improved treatment options for glaucoma with brimonidine-loaded lipid DNA nanoparticles","volume":"13","author":"Schnichels","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.heliyon.2024.e32602_bib56","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1080\/03639045.2022.2070198","article-title":"Formulation design and optimization of cationic-charged liposomes of brimonidine tartrate for effective ocular drug delivery by design of experiment (DoE) approach","volume":"47","author":"Soni","year":"2021","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.heliyon.2024.e32602_bib57","doi-asserted-by":"crossref","first-page":"30189","DOI":"10.1021\/acsami.0c07517","article-title":"MOF-based polymeric nanocomposite films as potential materials for drug delivery devices in ocular therapeutics","volume":"12","author":"Gandara-Loe","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.heliyon.2024.e32602_bib58","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1080\/02713683.2021.1916037","article-title":"Optimization and characterization of brimonidine tartrate nanoparticles-loaded in situ gel for the treatment of glaucoma","volume":"46","author":"Sharma","year":"2021","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.heliyon.2024.e32602_bib59","doi-asserted-by":"crossref","DOI":"10.1007\/s10971-020-05305-z","article-title":"Optimization and evaluation of encapsulated brimonidine tartrate-loaded nanoparticles incorporation in situ gel for efficient intraocular pressure reduction","volume":"95","author":"Sharma","year":"2020","journal-title":"J. Sol. Gel Sci. Technol."},{"key":"10.1016\/j.heliyon.2024.e32602_bib60","article-title":"Ophthalmic suspension of Brimonidine for sustained delivery using nano-resin\/drug complex technique","volume":"75","author":"Khopade","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.heliyon.2024.e32602_bib61","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/08853282221090880","article-title":"In vitro and in vivo evaluation of brimonidine loaded silica nanoparticles-laden silicone contact lenses to manage glaucoma","volume":"37","author":"Xu","year":"2022","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.heliyon.2024.e32602_bib62","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.sjbs.2020.03.013","article-title":"Effect of latanoprost on intraocular pressure, visual acuity and C-reactive protein","volume":"27","author":"Hou","year":"2020","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.heliyon.2024.e32602_bib63","first-page":"211","article-title":"In vivo analysis of prostaglandins-induced ocular surface and periocular adnexa modifications in patients with glaucoma","volume":"32","author":"S","year":"2018","journal-title":"In Vivo"},{"key":"10.1016\/j.heliyon.2024.e32602_bib64","first-page":"123","article-title":"Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye","volume":"7","author":"Natarajan","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.heliyon.2024.e32602_bib65","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s13346-014-0196-9","article-title":"Nanomedicine for glaucoma: sustained release latanoprost offers a new therapeutic option with substantial benefits over eyedrops","volume":"4","author":"Wong","year":"2014","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.heliyon.2024.e32602_bib66","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.exer.2013.04.007","article-title":"Biodegradable nanoparticles for controlled subconjunctival delivery of latanoprost acid: in vitro and in vivo evaluation. Preliminary results","volume":"112","author":"Giarmoukakis","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.heliyon.2024.e32602_bib67","doi-asserted-by":"crossref","first-page":"5629","DOI":"10.1167\/iovs.12-9513","article-title":"Development of latanoprost-loaded biodegradable nanosheet as a new drug delivery system for glaucoma","volume":"54","author":"Kashiwagi","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.heliyon.2024.e32602_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105748","article-title":"Latanoprost-loaded phytantriol cubosomes for the treatment of glaucoma","volume":"160","author":"Bessone","year":"2021","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.heliyon.2024.e32602_bib69","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00417-021-05536-y","article-title":"A novel ophthalmic latanoprost 0.005% nanoemulsion: a cytotoxicity study","volume":"260","author":"Tau","year":"2022","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.heliyon.2024.e32602_bib70","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.10.4.2","article-title":"Intraocular pressure reduction effect of 0.005% latanoprost eye drops in a hyaluronic acid-chitosan nanoparticle drug delivery system in albino rabbits","volume":"10","author":"Rubenicia","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.heliyon.2024.e32602_bib71","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.actbio.2022.03.015","article-title":"Iontophoretic ocular delivery of latanoprost-loaded nanoparticles via skin-attached electrodes","volume":"144","author":"Kim","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.heliyon.2024.e32602_bib72","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/10837450.2021.1999471","article-title":"Sustained latanoprost release from PEGylated solid lipid nanoparticle-laden soft contact lens to treat glaucoma","volume":"27","author":"Dang","year":"2022","journal-title":"Pharmaceut. Dev. Technol."},{"key":"10.1016\/j.heliyon.2024.e32602_bib73","article-title":"Self-assembled DNA nanoparticles loaded with travoprost for glaucoma-treatment","volume":"29","author":"Schnichels","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.heliyon.2024.e32602_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119402","article-title":"Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: improved pharmacokinetic\/pharmacodynamic properties","volume":"583","author":"Ismail","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.heliyon.2024.e32602_bib75","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/08982104.2022.2025828","article-title":"Spanlastics nanovesicular ocular insert as a novel ocular delivery of travoprost: optimization using Box-Behnken design and in vivo evaluation","volume":"32","author":"Shukr","year":"2022","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.heliyon.2024.e32602_bib76","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0161-6420(98)91421-X","article-title":"Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation","volume":"105","author":"Rosenberg","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.heliyon.2024.e32602_bib77","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/toxres\/tfaa066","article-title":"Investigating the ocular toxicity potential and therapeutic efficiency of in situ gel nanoemulsion formulations of brinzolamide","volume":"9","author":"Talaei","year":"2020","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.heliyon.2024.e32602_bib78","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejpb.2022.09.008","article-title":"Mucoadhesive brinzolamide-loaded nanofibers for alternative glaucoma treatment","volume":"180","author":"Cegielska","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.heliyon.2024.e32602_bib79","article-title":"Brinzolamide loaded core-shell nanoparticles for enhanced coronial penetration in the treatment of glaucoma","volume":"18","author":"Song","year":"2020","journal-title":"J. Appl. Biomater. Funct. Mater."},{"key":"10.1016\/j.heliyon.2024.e32602_bib80","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.ijbiomac.2019.10.219","article-title":"Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: formulation, characterization and pharmacodynamic study","volume":"152","author":"Dubey","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.heliyon.2024.e32602_bib81","article-title":"Formulation and evaluation of brinzolamide encapsulated niosomal in-situ gel for sustained reduction of IOP in rabbits","volume":"67","author":"Gupta","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.heliyon.2024.e32602_bib82","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2014.03.048","article-title":"Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo","volume":"467","author":"Tuomela","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.heliyon.2024.e32602_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/srep44229","article-title":"Creation of nano eye-drops and effective drug delivery to the interior of the eye","volume":"7","author":"Ikuta","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e32602_bib84","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1208\/s12249-009-9268-4","article-title":"Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride","volume":"10","author":"Ammar","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.heliyon.2024.e32602_bib85","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.3109\/03639041003801885","article-title":"Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery","volume":"36","author":"Ammar","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.heliyon.2024.e32602_bib86","article-title":"Formulation and optimization of cationic nanoemulsions for enhanced ocular delivery of dorzolamide hydrochloride using Box-Behnken design: in vitro and in vivo assessments","volume":"68","author":"Kassem","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.heliyon.2024.e32602_bib87","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1089\/jop.2013.0164","article-title":"Dorzolamide cyclodextrin nanoparticle suspension eye drops and Trusopt in rabbit","volume":"30","author":"Johannesson","year":"2014","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.heliyon.2024.e32602_bib88","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/jop.2013.0060","article-title":"gamma-Cyclodextrin nanoparticle eye drops with dorzolamide: effect on intraocular pressure in man","volume":"30","author":"Gudmundsdottir","year":"2014","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.heliyon.2024.e32602_bib89","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.carbpol.2013.10.079","article-title":"In situ gelling dorzolamide loaded chitosan nanoparticles for the treatment of glaucoma","volume":"102","author":"Katiyar","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.heliyon.2024.e32602_bib90","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/562727","article-title":"Development of dorzolamide loaded 6-o-carboxymethyl chitosan nanoparticles for open angle glaucoma","volume":"2013","author":"Shinde","year":"2013","journal-title":"J Drug Deliv"},{"key":"10.1016\/j.heliyon.2024.e32602_bib91","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.colsurfb.2014.07.004","article-title":"Dorzolamide-loaded PLGA\/vitamin E TPGS nanoparticles for glaucoma therapy: pharmacoscintigraphy study and evaluation of extended ocular hypotensive effect in rabbits","volume":"122","author":"Warsi","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.heliyon.2024.e32602_bib92","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijpharm.2017.02.035","article-title":"Enhanced ocular efficacy of topically-delivered dorzolamide with nanostructured mucoadhesive microparticles","volume":"522","author":"Park","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.heliyon.2024.e32602_bib93","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.ijbiomac.2019.08.107","article-title":"Leucaena leucocephala (Lam.) galactomannan nanoparticles: optimization and characterization for ocular delivery in glaucoma treatment","volume":"139","author":"Mittal","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.heliyon.2024.e32602_bib94","article-title":"Formulation, optimization and evaluation of vitamin E TPGS emulsified dorzolamide solid lipid nanoparticles","volume":"68","author":"Shahab","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.heliyon.2024.e32602_bib95","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1080\/03639045.2017.1386196","article-title":"Dorzolamide nanoliposome as a long action ophthalmic delivery system in open angle glaucoma and ocular hypertension patients","volume":"44","author":"Kouchak","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.heliyon.2024.e32602_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12080706","article-title":"Fasudil loaded PLGA microspheres as potential intravitreal depot formulation for glaucoma therapy","volume":"12","author":"Mietzner","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.heliyon.2024.e32602_bib97","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s13346-022-01266-8","article-title":"Cationic liposomes as promising vehicles for timolol\/brimonidine combination ocular delivery in glaucoma: formulation development and in vitro\/in vivo evaluation","volume":"13","author":"Bigdeli","year":"2023","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.heliyon.2024.e32602_bib98","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2174\/1566523218666171129205626","article-title":"Fabrication and characterization of timolol maleate and brinzolamide loaded nanostructured lipid carrier system for ocular drug delivery","volume":"15","author":"Shrivastava","year":"2018","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.heliyon.2024.e32602_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/ph13060126","article-title":"Ocular co-delivery of timolol and brimonidine from a self-assembling peptide hydrogel for the treatment of glaucoma: in vitro and ex vivo evaluation","volume":"13","author":"Taka","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.heliyon.2024.e32602_bib100","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.1021\/nn301873v","article-title":"Hybrid dendrimer hydrogel\/PLGA nanoparticle platform sustains drug delivery for one week and antiglaucoma effects for four days following one-time topical administration","volume":"6","author":"Yang","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.heliyon.2024.e32602_bib101","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/02652048909019905","article-title":"Manufacture of polyalkylcyanoacrylate nanoparticles with pilocarpine and timolol by micelle polymerization: factors influencing particle formation","volume":"6","author":"Harmia-Pulkkinen","year":"1989","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.heliyon.2024.e32602_bib102","first-page":"423","article-title":"Brinzolamide- and latanoprost-loaded nano lipid carrier prevents synergistic retinal damage in glaucoma","volume":"69","author":"Chen","year":"2022","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.heliyon.2024.e32602_bib103","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jksus.2019.09.011","article-title":"Promise of latanoprost and timolol loaded combinatorial nanosheet for therapeutic applications in glaucoma","volume":"32","author":"Wang","year":"2020","journal-title":"J. King Saud Univ. Sci."},{"key":"10.1016\/j.heliyon.2024.e32602_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121074","article-title":"Endogenous dual stimuli-activated NO generation in the conventional outflow pathway for precision glaucoma therapy","volume":"277","author":"Fan","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.heliyon.2024.e32602_bib105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.fct.2017.08.030","article-title":"Immunotoxicity, genotoxicity and epigenetic toxicity of nanomaterials: new strategies for toxicity testing?","volume":"109","author":"Dusinska","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.heliyon.2024.e32602_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032008","article-title":"Nanomaterials and their impact on the immune system","volume":"24","author":"Aljabali","year":"2023","journal-title":"Int. J. Mol. Sci."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402408633X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402408633X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:07:36Z","timestamp":1790543256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402408633X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":106,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S240584402408633X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32602","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research progress of nano delivery systems for intraocular pressure lowering drugs","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e32602"}}